Executive Summary: A Final Chapter of Growth
The Centers for Medicare & Medicaid Services (CMS) has released performance data for 2024 regarding the Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) model. The findings paint a picture of a maturing program that, despite facing a scheduled sunset, has achieved notable improvements in both quality metrics and aggregate financial savings for the Medicare program.
As the program prepares to transition into the newly announced ACO LEAD model in 2027, the 2024 data serves as a critical benchmark. While the program has faced significant hurdles—including provider apprehension regarding financial risk and high-profile losses among major industry players—the data suggests that the core mechanisms of value-based care are gaining traction. The transition to ACO LEAD is widely viewed by industry analysts as a strategic evolution designed to mitigate the volatility that characterized the REACH model while scaling the successes observed in high-needs patient management.
Chronology of a Value-Based Evolution
The journey toward ACO REACH—and now the forthcoming ACO LEAD—reflects a broader, decade-long shift in how the U.S. healthcare system incentivizes provider behavior.
- The Predecessor Era: Following the success of initial Medicare Shared Savings Programs (MSSP), CMS launched the Direct Contracting model to encourage more robust risk-sharing among providers.
- The Launch of ACO REACH (2023): In an effort to address criticisms of Direct Contracting—specifically regarding equity and beneficiary protections—CMS rebranded the initiative as ACO REACH. The model was designed to focus on high-needs populations and prioritize health equity.
- The Struggle for Participation (2023–2024): Throughout its lifespan, the model faced headwinds. Many providers, wary of the potential for significant financial losses, remained on the sidelines. Despite CMS implementing multiple "tweaks" to the risk-adjustment methodologies and participation incentives, organizations like Clover Health made headlines by exiting the program, citing the inherent volatility of the model.
- The Pivot to ACO LEAD (2027): Recognizing that the REACH model had reached its limit in terms of provider adoption, CMS announced it would not renew the program beyond 2026. Instead, it introduced the ACO LEAD (Longitudinal Engagement and Accountability for Delivery) model, which aims to incorporate lessons learned from the REACH era while offering a more stable regulatory environment.
Supporting Data: The 2024 Performance Landscape
The 2024 performance metrics provide a dual narrative: one of systemic progress and another of individual financial volatility.
Quality Benchmarks on the Rise
Perhaps the most significant takeaway from the 2024 data is the improvement in clinical quality. CMS reported that the average quality score for participating ACOs rose from 79.42% in 2023 to 81.11% in 2024. These scores are derived from rigorous assessments of clinical processes, including the reduction of hospital readmissions and the timely delivery of follow-up care. This upward trajectory suggests that as providers become more familiar with the administrative and clinical requirements of value-based care, patient outcomes are tangibly improving.
The Divergence of Financial Outcomes
While aggregate savings to Medicare were positive, the financial reality for individual ACOs varied wildly, largely dictated by the scale of their beneficiary populations.
- The High Performers: The Physicians Healthcare Collaborative, based in North Carolina, emerged as the top performer, generating a staggering $183.2 million in net savings. Other notable successes included ATLAS IPA in New York, and multi-state providers HarmonyCares and Bloom Health Network, all of which achieved net savings rates exceeding 25%.
- The Scale-Risk Paradox: Conversely, massive organizations faced significant financial turbulence. CVS, with a beneficiary population exceeding 210,000, reported a $69.5 million loss. Vytalize Health, managing over 160,000 beneficiaries, recorded the steepest loss of the year at $99.7 million.
The data reveals a "scale-risk paradox." Because these large entities operate on such a massive scale, even a modest net savings rate of -2.1% (for CVS) or -4.2% (for Vytalize) translates into tens of millions of dollars in losses. In contrast, smaller organizations—such as North East Medical Services or Arizona Best Care Network—experienced much sharper negative savings rates (up to -14.4%) but saw significantly smaller absolute dollar losses due to their smaller beneficiary pools. This highlights the inherent danger of "all-or-nothing" risk models for large-scale operations.
Official Responses and Industry Sentiment
The National Association of ACOs (NAACOS), which represents the interests of providers navigating these complex arrangements, has remained bullish on the results.
"The 2024 results demonstrate the success and impact of the model’s innovative design and focus on high-needs populations," said NAACOS CEO Emily Brower. "We look forward to seeing these features scale through the upcoming LEAD model."
For advocates of value-based care, the ACO REACH experiment was never intended to be the final word. Instead, it served as a laboratory for identifying which financial levers successfully drive down costs without compromising care. The industry consensus is that the "innovative design" Brower mentions—specifically the focus on social determinants of health and equity—has been the most valuable takeaway from the program.
Implications: The Road to ACO LEAD
The impending launch of ACO LEAD in 2027 is being framed by regulators and industry analysts alike as a necessary "correction" to the REACH model. By addressing the pain points that caused participation volatility, CMS hopes to bring more providers into the fold.
Key Features of the New Model
- Refined Benchmarking: ACO LEAD is expected to implement more accurate and responsive benchmarks, which have been a primary source of frustration for providers who felt the REACH benchmarks were often unattainable or misaligned with local market realities.
- Prospective Payments: By shifting toward more predictable payment structures, CMS aims to provide the cash-flow stability that risk-bearing organizations need to invest in infrastructure, such as care coordination technology and expanded primary care staffing.
- Extended Duration: The longer program duration is designed to allow organizations to plan long-term capital investments, moving away from the "short-termism" that defined the initial years of the REACH program.
- Leveling the Playing Field: The new model seeks to equalize participation for diverse types of providers, ensuring that both large-scale health systems and smaller, independent practices can participate without facing existential financial risks.
The Future of Value-Based Care
The transition from REACH to LEAD signifies a shift from "experimental" value-based care to "operational" value-based care. The 2024 data proves that while the model works in principle, the financial engineering behind it must be calibrated with extreme precision.
For the broader healthcare industry, the lesson of 2024 is clear: size does not inherently equate to success in risk-based contracting. Organizations that rely on broad-scale population management without robust, data-driven care coordination are likely to find themselves on the wrong side of the ledger. As the industry moves toward 2027, the focus will likely remain on optimizing the "middle ground"—creating arrangements that reward clinical excellence while shielding providers from the volatile, high-stakes financial swings that have hindered the adoption of value-based care for too long.
Ultimately, the sunsetting of ACO REACH is not an admission of failure, but a tactical pivot. CMS is betting that by integrating the quality successes of REACH into the more sustainable framework of LEAD, they can finally achieve the "triple aim" of healthcare: better health, better care, and lower costs.
